because it is going to all shareholders the 1 for 5 issue should be ok. this 15% ĺimit is a problem when a company does placements that dont involve all shareholders.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%